Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class ASSE: 688505

Announcement on Voluntary Disclosure Regarding the Completion of First Subject Enrollment in Confirmatory Clinical Trial for the Visualization of Bladder Cancer Surgery Using Aminolevulinic Acid Hydrochloride Granules

· Issued by Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure Regarding the Completion of First Subject Enrollment in Confirmatory Clinical Trial for the Visualization of Bladder Cancer Surgery Using Aminolevulinic Acid Hydrochloride Granules

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis